It comes as powder for injection (diluted with fluid), to be administered by a healthcare provider into the vein.
Kadcyla
Dosage & When it is to be taken
IV- The recommended dose is 3.6 mg/kg every 3 weeks (21-day cycle).When it is not to be taken (Contraindications)
None.Drug Name : Ado-trastuzumab Emtansine
Ado-trastuzumab Emtansine is used to treat HER2-positive metastatic breast cancer, a specific type of breast cancer that has moved to other parts of the body.Trade Names/Brand Names of Ado-trastuzumab Emtansine
International :
Kadcyla